Eric Venker - 20 Nov 2022 Form 4 Insider Report for Roivant Sciences Ltd. (ROIV)

Reporting relationship: President & COO
Issuer ticker: ROIV
Reported as of: 20 Nov 2022
Net transaction value: -$80,015
SEC form: 4
Accepted by SEC: 22 Nov 2022, 17:30:55 UTC
Prior SEC filing: 27 Oct 2022
Next SEC filing: 09 Dec 2022
Source filing: View source filing
Reporting owner signature: By: /s/ Jo Chen, as Attorney-in-Fact for Eric Venker

Key filing fact

Eric Venker filed Form 4 for Roivant Sciences Ltd. (ROIV) on 22 Nov 2022.

Key facts

This page summarizes Eric Venker's Form 4 filing for Roivant Sciences Ltd. (ROIV).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 22 Nov 2022, 17:30.

Change

Previous filing in this sequence was filed on 27 Oct 2022.
Current net transaction value: -$80,015.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ROIV transaction

Common Shares

Other

Transaction value: $80,015
Shares: -16,003
Change %: -1.5%
Price: $5.00
Shares after: 1,033,847
Date: 20 Nov 2022
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs.